• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲癌症研究与治疗组织QLQ-BIL21问卷用于测量胆管癌和胆囊癌患者生活质量的效度验证。

Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder.

作者信息

Kaupp-Roberts S D, Yadegarfar G, Friend E, O'Donnell C M, Valle J W, Byrne C, Bahar I, Finch-Jones M, Gillmore R, Johnson C D, Pereira S P, Wiggers J K, Pinto M, Al-Sarireh B, Ramage J K

机构信息

Department of Gastroenterology and Hepatology, Hampshire Hospitals NHS Foundation Trust, Aldermaston Road, Basingstoke RG24 9NA, UK.

Faculty of Humanities and Social Sciences, University of Winchester, Sparkford Road, Winchester SO22 4NR, UK.

出版信息

Br J Cancer. 2016 Oct 25;115(9):1032-1038. doi: 10.1038/bjc.2016.284. Epub 2016 Sep 27.

DOI:10.1038/bjc.2016.284
PMID:27673364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5117782/
Abstract

BACKGROUND

There is no specific quality of life (QoL) measurement tool to quantify QoL in patients with biliary tract cancer. Quality of life measurement is an increasingly crucial trial end point and is now being incorporated into clinical practice.

METHODS

This International Multicentre Phase IV Validation Study assessed the QLQ-BIL21 module in 172 patients with cholangiocarcinoma and 91 patients with cancer of the gallbladder. Patients completed the questionnaire at baseline pretherapy and subsequently at 2 months. Following this, the psychometric properties of reliability, validity, scale structure and responsiveness to change were analysed.

RESULTS

Analysis of the QLQ-BIL21 scales showed appropriate reliability with Cronbach's α-coefficients >0.70 for all scales overall. Intraclass correlations exceeded 0.80 for all scales. Convergent validity >0.40 was demonstrated for all items within scales, and discriminant validity was confirmed with values <0.70 for all scales compared with each other. Scale scores changed in accordance with Karnofsky performance status and in response to clinical change.

CONCLUSIONS

The QLQ-BIL21 is a valid tool for the assessment of QoL in patients with cholangiocarcinoma and cancer of the gallbladder.

摘要

背景

目前尚无专门用于量化胆管癌患者生活质量(QoL)的测量工具。生活质量测量在试验终点方面愈发关键,如今已被纳入临床实践。

方法

这项国际多中心IV期验证研究对172例胆管癌患者和91例胆囊癌患者的QLQ - BIL21模块进行了评估。患者在基线治疗前以及随后的2个月时完成问卷。在此之后,分析了该问卷在可靠性、有效性、量表结构以及对变化的反应性等方面的心理测量特性。

结果

对QLQ - BIL21量表的分析表明,总体而言所有量表的克朗巴哈α系数>0.70,具有适当的可靠性。所有量表的组内相关系数均超过0.80。各量表内所有项目的收敛效度>0.40,并且相互比较时所有量表的值<0.70,证实了区分效度。量表得分根据卡诺夫斯基功能状态评分以及临床变化而改变。

结论

QLQ - BIL21是评估胆管癌和胆囊癌患者生活质量的有效工具。

相似文献

1
Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder.欧洲癌症研究与治疗组织QLQ-BIL21问卷用于测量胆管癌和胆囊癌患者生活质量的效度验证。
Br J Cancer. 2016 Oct 25;115(9):1032-1038. doi: 10.1038/bjc.2016.284. Epub 2016 Sep 27.
2
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.开发了一个问卷(EORTC 模块),用于测量胆管癌和胆囊癌患者的生活质量,即 EORTC QLQ-BIL21。
Br J Cancer. 2011 Feb 15;104(4):587-92. doi: 10.1038/sj.bjc.6606086. Epub 2011 Jan 25.
3
The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.欧洲癌症研究与治疗组织(EORTC)生活质量调查问卷宫颈癌模块:EORTC QLQ-CX24。
Cancer. 2006 Oct 15;107(8):1812-22. doi: 10.1002/cncr.22217.
4
Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).欧洲癌症研究与治疗组织子宫内膜癌生活质量问卷模块(EORTC QLQ-EN24)的独立心理测量学验证
Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12639. Epub 2017 Jan 6.
5
Biliary tract cancer.胆道癌
Cancer Treat Res. 1997;90:273-307. doi: 10.1007/978-1-4615-6165-1_15.
6
Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.评估乳腺癌患者生活质量的问卷——欧洲癌症研究与治疗组织QLQ-BR 53中文版的验证
Breast. 2017 Apr;32:87-92. doi: 10.1016/j.breast.2016.12.019. Epub 2017 Jan 7.
7
Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.肺癌患者的健康相关生活质量:EORTC QLQ-LC13 问卷的墨西哥西班牙语版验证及其与预后的关系。
Lung Cancer. 2012 Jul;77(1):205-11. doi: 10.1016/j.lungcan.2012.02.005. Epub 2012 Mar 3.
8
[Cultural adaptation and psychometric validation of the health-related quality of life questionnaire EORTC QLQ STO-22 for patients with gastric cancer in Peru].
Rev Gastroenterol Peru. 2015 Apr-Jun;35(2):127-35.
9
Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period.胆管癌患者的生存和生活质量:一项为期 4 年的前瞻性研究。
J Gastrointestin Liver Dis. 2010 Sep;19(3):285-90.
10
Validation of EORTC QLQ-LC43 for Chinese patients with lung cancer.EORTC QLQ-LC43 在中国肺癌患者中的验证。
Lung Cancer. 2014 Jul;85(1):94-8. doi: 10.1016/j.lungcan.2014.04.006. Epub 2014 Apr 20.

引用本文的文献

1
Clinical outcomes of percutaneous biliary drainage and quality of life assessment: a prospective observational study.经皮胆道引流的临床结局与生活质量评估:一项前瞻性观察性研究。
Abdom Radiol (NY). 2025 Jul 25. doi: 10.1007/s00261-025-05140-2.
2
Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction (TESLA RCT): study protocol for a multicenter randomized controlled trial.壶腹上方原发性经皮支架置入术与内镜引流术治疗不可切除性恶性肝门部胆管梗阻的比较(TESLA随机对照试验):一项多中心随机对照试验的研究方案
BMC Cancer. 2025 May 9;25(1):849. doi: 10.1186/s12885-025-14158-0.
3
The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer).用于评估晚期肝内胆管癌(胆管癌)患者健康相关生活质量(HRQOL)的癌症治疗功能评估肝胆版(FACT-Hep)的首次验证。
PLoS One. 2025 Apr 28;20(4):e0321618. doi: 10.1371/journal.pone.0321618. eCollection 2025.
4
Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysis.培米替尼在携带FGFR融合或重排的晚期胆管癌中的疗效和毒性:一项系统评价和荟萃分析
Target Oncol. 2025 May;20(3):389-403. doi: 10.1007/s11523-025-01142-8. Epub 2025 Apr 13.
5
Health-Related Quality of Life (HRQoL) Assessments in Research on Patients with Adult Rare Solid Cancers: A State-of-the-Art Review.成人罕见实体癌患者研究中的健康相关生活质量(HRQoL)评估:最新综述
Cancers (Basel). 2025 Jan 24;17(3):387. doi: 10.3390/cancers17030387.
6
Effectivity of Palliative Care Bundle on Advanced Gallbladder Cancer: A Randomised Controlled Trial.姑息治疗套餐对晚期胆囊癌的有效性:一项随机对照试验
Indian J Palliat Care. 2023 Oct-Dec;29(4):447-455. doi: 10.25259/IJPC_33_2023. Epub 2023 Nov 11.
7
Development of a Patient-Reported Symptom Item Bank for Patients with Hepatobiliary or Pancreatic Malignancies: A Systematic Review.肝胆或胰腺恶性肿瘤患者自我报告症状条目库的开发:一项系统综述
Patient Prefer Adherence. 2023 Jan 19;17:199-207. doi: 10.2147/PPA.S398666. eCollection 2023.
8
Gallbladder cancer.胆囊癌。
Nat Rev Dis Primers. 2022 Oct 27;8(1):69. doi: 10.1038/s41572-022-00398-y.
9
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study.改良FOLFIRINOX方案作为吉西他滨治疗失败的晚期胆管癌患者的二线治疗:一项前瞻性多中心II期研究
Cancers (Basel). 2022 Apr 13;14(8):1950. doi: 10.3390/cancers14081950.
10
Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas.选择性内放射联合化疗维持肝内胆管细胞癌患者的生活质量。
Curr Oncol. 2021 Nov 8;28(6):4530-4541. doi: 10.3390/curroncol28060384.

本文引用的文献

1
Factors Affecting Health-Related Quality of Life in Patients With Cholangiocarcinoma in the Northeastern Region of Thailand.泰国东北部胆管癌患者健康相关生活质量的影响因素
Cancer Nurs. 2015 Nov-Dec;38(6):E46-51. doi: 10.1097/NCC.0000000000000233.
2
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.开发了一个问卷(EORTC 模块),用于测量胆管癌和胆囊癌患者的生活质量,即 EORTC QLQ-BIL21。
Br J Cancer. 2011 Feb 15;104(4):587-92. doi: 10.1038/sj.bjc.6606086. Epub 2011 Jan 25.
3
Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period.胆管癌患者的生存和生活质量:一项为期 4 年的前瞻性研究。
J Gastrointestin Liver Dis. 2010 Sep;19(3):285-90.
4
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.顺铂联合吉西他滨与吉西他滨治疗胆管癌。
N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.
5
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study.吉西他滨单药或联合顺铂用于晚期或转移性胆管癌或其他胆道肿瘤患者:一项多中心随机II期研究——英国ABC-01研究
Br J Cancer. 2009 Aug 18;101(4):621-7. doi: 10.1038/sj.bjc.6605211.
6
Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.欧洲癌症研究与治疗组织QLQ-LMC21问卷用于评估结直肠肝转移瘤治疗期间患者报告结局的效度验证。
Br J Surg. 2009 Mar;96(3):291-8. doi: 10.1002/bjs.6471.
7
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.胆管癌:一家机构对564例患者长达31年的经验总结。
Ann Surg. 2007 May;245(5):755-62. doi: 10.1097/01.sla.0000251366.62632.d3.
8
Cholangiocarcinoma: emerging approaches to a challenging cancer.胆管癌:应对这一具有挑战性癌症的新方法
Curr Opin Gastroenterol. 2007 May;23(3):317-23. doi: 10.1097/MOG.0b013e3280495451.
9
Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.卡培他滨和顺铂用于既往未治疗的晚期胆管癌的II期研究。
Cancer Chemother Pharmacol. 2007 Aug;60(3):321-8. doi: 10.1007/s00280-006-0380-9. Epub 2006 Dec 2.
10
Cholangiocarcinoma: modern advances in understanding a deadly old disease.胆管癌:认识一种致命的古老疾病的现代进展
J Hepatol. 2006 Dec;45(6):856-67. doi: 10.1016/j.jhep.2006.09.001. Epub 2006 Sep 25.